Steven Stone, PhD

Steven Stone, PhD, is the Executive Vice President at Envision Sciences. Dr. Stone earned his PhD in Genetics and Molecular Biology from the University of Minnesota in Minneapolis. Dr. Stone specializes in developing molecular diagnostics, with over 25 years in the field. He has authored or co-authored over 50 peer-reviewed publications and 10 U.S. patents.

Before joining Envision Sciences, Dr. Stone was Senior Vice President for the Research and Development Department at DermTech, where he directed research and development of molecular tests to support clinical management of dermatology patients. Prior to DermTech, Dr. Stone was Vice President of the Kidney Care Department at CareDX. His research groups were responsible for the research and development of molecular tests including AlloMap, HistoMap, and UroMap. Before which, he spent 25 years at Myriad Genetics. He became the Vice President of Cancer Genomics, where his group was responsible for  the development of a molecular prognostic test for newly diagnosed prostate cancer (Prolaris). Also while at Myriad, he was involved in the discovery and characterisation of several important cancer genes including BRCA1 and p16.